Skip to main content

kat6a/b inhibitor bg-75202

Generic: KAT6A/B Inhibitor BG-75202

kat6a/b inhibitor bg-75202: 2 clinical trials tracked.

kat6a/b inhibitor bg-75202 evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about kat6a/b inhibitor bg-75202, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors
Clinical Trial Registry Records (2)

A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BG-75202, Alone and in Combination With Other Agents, in Patients With Myeloid Malignancies

NCT07619287Registry updated 2026-09-28·Phase 1·ONC
Recruiting

Primary endpoint: Part 1a: Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs)

Interventionalopen118 targetStarted 2026-06Completion 2028-0917 sites · Australia, China, New ZealandBeOne Medicines

A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-75202, Alone and in Combination With Other Agents in Patients With Advanced Solid Tumors

NCT07222267Registry updated 2026-09-28·Phase 1·ONC
Recruiting

Primary endpoint: Part 1: Number of Participants with Adverse Events (AEs)

Interventionalopen86 targetStarted 2025-12Completion 2037-0132 sites · Australia, China, Italy, New Zealand…BeOne Medicines